PET Faces A No-Win Situation At MCAC Review Of Alzheimer’s Treatment

The Medicare Coverage Advisory Committee Diagnostic Imaging Panel's rejection of PET imaging for use in treating Alzheimer's disease demonstrates that diagnostic coverage reviews in the future may depend as much on the treatment in question as the diagnostic itself